Genetic Alliance UK announces new role for Alastair Kent
Last Reviewed 3/04/2017
In September 2016 we announced that our longstanding Director, Alastair Kent OBE, would be retiring from the role in April 2017. Genetic Alliance UK has subsequently appointed a new CEO, Dr Jayne Spink, who has already had a successful tenure as CEO at the Tuberous Sclerosis Association and will bring her scientific, campaigning and management skills to further develop our long term aims of supporting, campaigning and uniting patients with genetic conditions and their families.
We are now pleased to announce that following his retirement from the role of Executive Director of Genetic Alliance UK Alastair will be assuming a new, part-time role with the charity at the beginning of May 2017 when he will become Ambassador for the charity. As Ambassador, Alastair will continue to promote the needs of patients and families with rare and genetic diseases for high quality services and support. Alastair will focus on the international aspects of Genetic Alliance UK’s mission and will in addition continue as Chair of Rare Disease UK. He will also undertake a limited number of public speaking engagements.
Speaking about this new role, Alastair said:
“I am delighted that I will continue to work with my friends and colleagues at Genetic Alliance UK – an organisation whose mission I am passionate about. I am excited by the potential that we can see for achieving real change for our members and for the individuals and families who they support. I look forward to supporting Jayne Spink as she assumes the role of CEO of the charity, bringing fresh eyes and new expertise to our work.”
Jayne Spink said:
“I’m so pleased that Alastair will be remaining part of the team as our Ambassador. Alastair’s wealth of experience will be a great asset and I very much look forward to working with him.”
Christopher Goard Chair of Genetic Alliance UK said:
“I am delighted that we will continue to benefit from Alastair’s enthusiasm and commitment to the needs of patients with genetic disorders. In addition, Alastair’s support for our new CEO Dr Jayne Spink, will provide useful continuity as she builds her executive team and her essential leadership role of the charity”